Long-term survivors in severe aplastic anemia: standard mortality rates now comparable to controls?
- PMID: 37439355
- PMCID: PMC10690898
- DOI: 10.3324/haematol.2023.283523
Long-term survivors in severe aplastic anemia: standard mortality rates now comparable to controls?
Comment on
-
Conditional survival and standardized mortality ratios of patients with severe aplastic anemia surviving at least one year after hematopoietic cell transplantation or immunosuppressive therapy.Haematologica. 2023 Dec 1;108(12):3298-3307. doi: 10.3324/haematol.2023.282781. Haematologica. 2023. PMID: 37259612 Free PMC article.
References
-
- Socié G, Henry-Amar M, Bacigalupo A, et al. Malignant tumors occurring after treatment of aplastic anemia. European Bone Marrow Transplantation-Severe Aplastic Anaemia Working Party. N Engl J Med. 1993;329(16):1152-1157. - PubMed
-
- Moore MA, Castro-Malaspina H. Immunosuppression in aplastic anemia--postponing the inevitable? N Engl J Med. 1991;324(19):1358-1360. - PubMed
-
- Bacigalupo A, Socié G, Hamladji RM, et al. Aplastic Anemia Working Party of the European Group for Blood Marrow Transplantation. Current outcome of HLA identical sibling versus unrelated donor transplants in severe aplastic anemia: an EBMT analysis. Haematologica. 2015;100(5):696-702. - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
